Search Results 681-690 of 18436 for Prednisone
Patients treated with dexamethasone \> 2 mg/day or equivalent (i.e. 13 mg/day of prednisone, or 53 mg/day of hydrocortisone) within 14 days before the first ...
Prior and concomitant therapy: Participants who have taken systemic corticosteroids at a dose exceeding 20 mg/day prednisone or equivalent for more than 7 ...
Chronic systemic corticosteroid use, defined as > 20 mg of prednisone or equivalent systemic corticosteroid taken for more than 4 consecutive weeks within 6 ...
Use of systemic steroids at an equivalent dose of prednisone 5 mg/day or higher at the time of study entry; Any history of seizures or medical condition ...
... prednisone at doses of > 10 mg). Inhaled or topical steroids and adrenal/pituitary replacement doses ≤ 10mg daily of prednisone or equivalent are permitted ...
Lumacaftor; Mitotane; Modafinil; Nafcillin; Nevirapine; Oxcarbazepine; Phenobarbital; Phenytoin; Prednisone; Primidone; Rifabutin; Rifampin; Ritonavir; St ...
Subjects on oral corticosteroids (e.g., prednisone, budesonide) at a prednisone-equivalent dose of ≤ 40 mg/day or ≤ 9 mg/day of budesonide are permitted ...
... prednisone, dexamethasone) or continuous use of topical steroid creams or ointments or ophthalmologic steroids. A history of occasional (but not continuous) ...
Subject is taking > 10 mg of prednisolone or prednisone per day. Subject has an implantable cardioverter defibrillator or pacemaker. Subject has a history ...
Note: At screening, subjects may be using systemic corticosteroids (at doses of ≤10 mg of prednisone or equivalent) or topical or inhaled corticosteroids.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.